Management of Endoscopic Portal Hypertension Lesions in Cirrhotic Patients in a Country with Limited Resources: About 603 Cases in the City of Douala in Cameroon
- 1 Department of Internal Medicine, the Douala General Hospital, Douala, Cameroon
- 2 Faculty of Medicine, University of Buea, Buea, Cameroon
- 3 Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon
- 4 Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon
- 5 Department of Internal Medicine, the Douala General Hospital, Douala, Cameroon
- 6 Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon
- 7 Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon
- 8 Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon
- 9 Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon
- 10 Department of Internal Medicine, the Douala General Hospital, Douala, Cameroon
- 11 Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon
Abstract
Introduction: Portal hypertension (HTP) is a morbi-mortality factor in cirrhotic patients. It is responsible for endoscopic lesions and has digestive hemorrhage as the main complication. The objective of the study was to study the management of endoscopic lesions of portal hypertension in a country with limited resources. Methodology: This was a cross-sectional and analytical study conducted in 04 hospitals in the city of Douala, Cameroon, over a period of 08 years from 1 January 2014 to 31 December 2022. Included were cirrhotic patients with viral hepatitis with endoscopic lesions of PH. The data collected were sociodemographic, clinical, paraclinical, therapeutic and evolutionary. Data analysis was done using SPSS software version 25.0. Logistic regression allowed the search for prognostic factors with a significance threshold of p < 0.005. Results: We included 603 patient records. They were mainly male patients (56.1%) with an average age of 47.6 ± 6.3 years. The Child Pugh score was ranked B in 53.7% of cases. Digestive hemorrhage was the main complication in 66.8% of cases. We had grade 2 esophageal varices in 61.5% of cases. The main treatments were prescription of propanolol (63.3%) and ligation of esophageal varices (53.3%). The average number of ligation sessions was 2.1 ± 1.8 with an interval between sessions of 28 ± 2.8 days. Prevention of rupture of esophageal varices was secondary in 66.5% of cases (n = 452). The rate of hemorrhagic recurrence was 9.3%. Hospital mortality was 15.1%. Recurrence of hemorrhage was associated with PT < 45% (OR = 1.04; 95% CI [1.01-1.06]; p = 0.003) and platelet levels < 150,000/mm3 (OR = 1.05; CI 95%: [1-1.09], p = 0.029). Mortality was associated with a child pugh C score (OR = 9.73; 95% CI 95% [3.9-23.9]; p < 0.005) and hemorrhagic recurrence (OR = 2.02; 95% CI 95% [0.9-4.3]; p < 0.005). Conclusion: The management of HTP lesions was based on the prescription of beta-blockers and the ligation of esophageal varices. Factors associated with mortality were hemorrhagic recurrence, low PT and Child Pugh C score.
- Maeva, G., Jean-Paul, C., Carine, C.D., Aurélie, P. and Nicolas, C. (2015) Hyperten-sion Portale: Physiopathologie, Causes, Diagnostic et Traitement. Hépato-Gastro & Oncologie Digestive, 22, 40-56.
- Chagneau-Derrode, C. and Silvain, C. (2005) Physiopathologie de l’hypertension portale: Mise à jour. EMC—Hépato-Gastroenterologie, 2, 264-268. https://doi.org/10.1016/j.emchg.2005.01.010
- Gunarathne, L.S., Rajapaksha, H., Shackel, N., Angus, P.W. and Herath, C.B. (2020) Cirrhotic Portal Hypertension: From Pathophysiology to Novel Therapeutics. World Journal of Gastroenterology, 26, 6111-6140. https://doi.org/10.3748/wjg.v26.i40.6111
- Khanna, R. and Sarin, S.K. (2014) Non-Cirrhotic Portal Hypertension—Diagnosis and Management. Journal of Hepatology, 60, 421-441. https://pubmed.ncbi.nlm.nih.gov/23978714/ https://doi.org/10.1016/j.jhep.2013.08.013
- Gulamhusein, A.F. and Kamath, P.S. (2017) The Epidemiology and Pathogenesis of Gastrointestinal Varices. Techniques in Gastrointestinal Endoscopy, 19, 62-68. https://doi.org/10.1016/j.tgie.2017.03.005
- Ouattara, A., Coffi, D.F., Assi, C., Soro, D., Allah-Kouadio, E. and Kouacou, L. (2018) Lésions endoscopiques hautes chez le cirrhotique au Centre Hospitalier et Universitaire de Cocody [Upper Digestive Endoscopy Lesions among Cirrhotics in the University Teaching Hospital of Cocody in Cote d’Ivoire]. Revue Internationale des Sciences Médicales, 20, 297-300.
- Bassene, M.L., Diouf, M.L., Dia, D., Mbengue, M., Halim, A., Diallo, S., et al. (2012) La ligature élastique des varices œsophagiennes à Dakar (Sénégal). Médecine et Santé Tropicales, 22, 166-169. https://doi.org/10.1684/mst.2012.0046
- Tapouh, J.M., Njoya, O., Zoé, C.M., Moifo, B., Kowo, M. and Amvene, S.N. (2015) Approche non Endoscopique du Diagnostic des Varices Œsophagiennes d’Origine Cirrhotique dans une Population d’Afrique Noire Subsaharienne. Health Sciences and Diseases, 16.
- De Franchis, R., Bosch, J., Garcia-Tsao, G., Reiberger, T., Ripoll, C., Abraldes, J.G., et al. (2022) Baveno VII—Renewing Consensus in Portal Hypertension. Journal of Hepatology, 76, 959-974.
- Doffou, S.A., Assi, C., Hamidine, I., Bangoura, D., Kouamé, D., Yaogo, A., et al. (2022) Valeur prédictive négative du ratio taux de plaquettes sur diamètre de la rate pour exclure la présence de varices œsophagiennes chez le cirrhotique d’origine virale B. Revue de Médecine et de Pharmacie, 11, 1208-1212.
- LaBrecque, D., Khan, A.G., Sarin, S.K., Le Mair, A.W., Gonvers, J.J., Dite, P., et al. (2014) Varices Oesophagiennes. World Gastroenterology Practice Guidelines.